PerkinElmer, Inc. (NYSE:PKI) updated its FY17 earnings guidance on Thursday. The company provided EPS guidance of $2.84-2.92 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.85.

Several research firms have recently issued reports on PKI. Jefferies Group LLC reissued a hold rating and issued a $69.00 price target (up previously from $58.00) on shares of PerkinElmer in a research note on Tuesday, June 20th. Cantor Fitzgerald reissued a hold rating and issued a $65.00 price target on shares of PerkinElmer in a research note on Monday, May 15th. Barclays PLC set a $55.00 price target on PerkinElmer and gave the stock a sell rating in a research note on Saturday, May 6th. Citigroup Inc. increased their price target on PerkinElmer from $57.00 to $67.00 and gave the stock a buy rating in a research note on Friday, April 7th. Finally, BidaskClub cut PerkinElmer from a strong-buy rating to a buy rating in a research note on Wednesday, June 14th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and six have issued a buy rating to the company. PerkinElmer currently has a consensus rating of Hold and an average target price of $64.93.

Shares of PerkinElmer, Inc. (NYSE PKI) traded down 3.10% during midday trading on Friday, hitting $64.29. The stock had a trading volume of 1,510,742 shares. The firm has a market capitalization of $7.07 billion, a PE ratio of 31.35 and a beta of 0.75. The firm’s 50-day moving average price is $67.63 and its 200-day moving average price is $60.20. PerkinElmer, Inc. has a one year low of $45.35 and a one year high of $70.16.

PerkinElmer (NYSE:PKI) last released its earnings results on Thursday, August 3rd. The medical research company reported $0.67 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.67. The company had revenue of $547 million during the quarter, compared to analysts’ expectations of $554.14 million. PerkinElmer had a return on equity of 13.87% and a net margin of 16.80%. The business’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same period last year, the firm earned $0.67 EPS. On average, equities analysts predict that PerkinElmer, Inc. will post $2.86 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, October 20th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Thursday, October 19th. This represents a $0.28 annualized dividend and a dividend yield of 0.44%. PerkinElmer’s dividend payout ratio (DPR) is currently 8.46%.

In other news, insider Andrew Okun sold 4,358 shares of the firm’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $65.00, for a total value of $283,270.00. Following the transaction, the insider now directly owns 16,799 shares in the company, valued at approximately $1,091,935. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Patrick J. Sullivan sold 6,628 shares of the firm’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $62.59, for a total value of $414,846.52. Following the completion of the transaction, the director now owns 42,951 shares in the company, valued at $2,688,303.09. The disclosure for this sale can be found here. Insiders sold a total of 20,986 shares of company stock worth $1,330,317 over the last 90 days. 2.20% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This story was originally published by Daily Political and is owned by of Daily Political. If you are reading this story on another domain, it was illegally copied and reposted in violation of US & international copyright law. The legal version of this story can be read at

About PerkinElmer

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Earnings History and Estimates for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with's FREE daily email newsletter.